Belgium· BE-AMP-SAM434366-00

Aromasin 25 mg

A exemestane product containing exemestane, registered in Belgium by PI Pharma. The same ATC class is registered in 17 of our 19 countries.

ATC L02BG06

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about exemestaneAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Exemestane is registered in 17 of 19 countries.

Countries holding a registration under ATC L02BG06 (exemestane), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search exemestane products by name

Exemestane · ATC L02BG06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of exemestane costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $1.43 in France to $3.32 in Switzerland — a ×2.3 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Exemestane · price per daily dose (25 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.32
IT Italy$2.46
FR France$1.43

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Exemestane
Manufacturer: PI Pharma
Country: Belgium (BE)
ATC code: L02BG06
ATC class: Exemestane
Defined daily dose: 25 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

be_apb
3363272
be_apb
3057411
be_apb
7703614

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

236 interactions on record for exemestane.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check exemestane against other medicines How interaction checks work

Exemestane · interactions on record

236 records

1 severe
83 moderate
152 info

Most severe, free to view

ThalidomideL04AX02severe
TroglitazoneA10BG01moderate
SulfinpyrazonB01AC12moderate
FostamatinibB02BX09moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Exemestane in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exemestane products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Aromasin, Exemestan Accord
Bulgaria · Аромазин, Екземегратис
Cyprus · Exedral
Czechia · Aromasin, Astexana
Germany · Aromasin, Exemestan 1 A Pharma
Denmark · Aromasin, Exemestan Accord
Estonia · Aromasin, Exemestane Accord
Spain · Aromasil, Exemestano Aurovitas
Finland · Aromasin, Exemestan Pfizer
France · Aromasine, Exemestane Accord
United Kingdom (Northern Ireland) · Aromasin, Exemestane
Greece · Aromaplex, Aromasin
Croatia · Aromasin, Eksemestan Jgl
Hungary · Aromasin, Exemestane Pharmacenter
Ireland · Aromasin, Exemestane Accord
Iceland · Aromasin, Exemestan Actavis
Italy · Aromasin, Axelta
Lithuania · Aromasin, Exemestane Accord
Luxembourg · Aromasin, Exemestan Ratiopharm
Latvia · Exemestane Accord, Exemestane Sanoswiss
Malta · Aromasin, Exedral 25
Netherlands · Aromasin, Exemestaan Accord
Norway · Aromasin, Exemestan Sandoz
Poland · Astexana, Glandex
Portugal · Aromasin, Exemestano Accord
Romania · Aromasin, Exemestan Accord
Sweden · Exemestan Actavis, Exemestan Sandoz
Slovenia · Aromasin
Slovakia · Aromasin, Astexana

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/6b1ece05-fd98-4605-b4e8-696eaf103b69
GET /v1/drugs/6b1ece05-fd98-4605-b4e8-696eaf103b69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Aromasin 25 mg",
  "name_fr": "Aromasin 25 mg",
  "name_nl": "Aromasin 25 mg",
  "amp_code": "SAM434366-00",
  "strengths": [
    "25.0000",
    "25.0000",
    "25.0000"
  ],
  "pack_count": 18,
  "substances": [
    "Exemestane"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Exemestane",
  "authorisation_numbers": [
    "1637PI0369F003",
    "1637PI0439F003"
  ]
}

API reference MCP server Plans

See everything about exemestane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console